Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALEXANDER E GLICK

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1598081911
CMS profile
253026
Location
SARASOTA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,583.61

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,725.40 123
Consulting Fee $840.00 1
Education $18.21 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALEXANDER E GLICK

NPI 1598081911 · CMS profile ID 253026

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

SARASOTA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598081911?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598081911?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598081911?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ALEXANDER E GLICK, NPI 1598081911, CMS profile ID 253026, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1598081911?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $3,583.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $20.2308/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049469711 CMS
Novartis Pharmaceuticals Corporation $21.3308/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992310813 CMS
Janssen Biotech, Inc. $14.6408/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988270265 CMS
Janssen Biotech, Inc. $15.8908/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988270287 CMS
Merck Sharp & Dohme LLC $23.5408/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048748457 CMS
GlaxoSmithKline, LLC. $23.0008/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002656438 CMS
PharmaEssentia USA Corporation $28.6408/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059318527 CMS
PFIZER INC. $16.4508/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050701367 CMS
CTI BioPharma Corp. $15.2507/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039687651 CMS
Astellas Pharma US Inc $13.0107/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034341813 CMS
Astellas Pharma US Inc $23.7007/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034335009 CMS
PFIZER INC. $18.9807/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050701365 CMS
Amgen Inc. $16.6407/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020529319 CMS
Merck Sharp & Dohme LLC $28.8607/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048377771 CMS
Genmab U.S., Inc. $22.1307/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051342061 CMS
Gilead Sciences, Inc. $26.3407/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025599129 CMS
Janssen Biotech, Inc. $16.6207/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988270277 CMS
Astellas Pharma US Inc $16.6707/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034251187 CMS
Incyte Corporation $25.7607/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044623075 CMS
Janssen Scientific Affairs, LLC $840.0007/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988570663 CMS
Gilead Sciences, Inc. $20.8206/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025786525 CMS
Celgene Corporation $19.1606/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015498689 CMS
E.R. Squibb & Sons, L.L.C. $19.1306/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015498677 CMS
Merck Sharp & Dohme LLC $18.2006/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048381409 CMS
Stemline Therapeutics Inc. $21.5806/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040019905 CMS
SERVIER PHARMACEUTICALS LLC $21.1106/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055084359 CMS
AVEO Pharmaceuticals, Inc. $17.1106/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049055079 CMS
Novartis Pharmaceuticals Corporation $18.4206/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992310791 CMS
Bayer Healthcare Pharmaceuticals Inc. $141.5906/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000699437 CMS
Gilead Sciences, Inc. $23.1106/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025704611 CMS
Genmab U.S., Inc. $15.3505/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051342059 CMS
Novartis Pharmaceuticals Corporation $19.4605/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992310787 CMS
Exelixis Inc. $21.3405/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044561137 CMS
Seagen Inc. $15.5005/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995830879 CMS
E.R. Squibb & Sons, L.L.C. $12.1505/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015498653 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.4405/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055392585 CMS
Seagen Inc. $12.7205/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995830865 CMS
Seagen Inc. $16.9005/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995830895 CMS
Merck Sharp & Dohme LLC $29.1904/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048378019 CMS
JAZZ PHARMACEUTICALS INC. $29.3804/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058399747 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.5804/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996834527 CMS
Incyte Corporation $22.5104/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044623051 CMS
Merck Sharp & Dohme LLC $20.4004/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048378023 CMS
Merck Sharp & Dohme LLC $12.5204/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048378017 CMS
Kyowa Kirin, Inc. $18.5504/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026984733 CMS
Novartis Pharmaceuticals Corporation $18.3704/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992310783 CMS
Genentech USA, Inc. $17.3303/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040287621 CMS
BeiGene USA, Inc. $21.8903/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051193163 CMS
Daiichi Sankyo Inc. $27.8003/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006339825 CMS
Telix Pharmaceuticals $24.5603/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005794547 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,194.07 152
PY2020 $1,277.71 60
PY2021 $1,553.35 97
PY2022 $2,093.21 107
PY2023 $3,583.61 125
PY2024 $4,308.86 117
PY2025 $4,720.73 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $313,687.93 11
PY2024 Recipient $1,402.00 1
PY2024 Principal investigator $165,343.75 14
PY2023 Recipient $6,838.35 2
PY2023 Principal investigator $21,350.75 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Scientific Affairs, LLC $27,000.00 12/18/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941406
Principal investigator 1 Janssen Scientific Affairs, LLC $15,000.00 11/05/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941431
Principal investigator 1 Janssen Scientific Affairs, LLC $33,000.00 09/18/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941418
Principal investigator 1 Janssen Scientific Affairs, LLC $75,000.00 08/28/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941441
Principal investigator 1 Eli Lilly and Company $13,319.00 06/10/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187889048
Principal investigator 1 Janssen Scientific Affairs, LLC $2,000.00 05/29/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941464
Principal investigator 1 Janssen Scientific Affairs, LLC $60,000.00 05/22/2025 Non-covered Recipient Entity
Fl Cancer Specialists and Rsrch Inst
Longitudinal Multi-Center Chart Review Data Repository For Multiple Myeloma No dispute reported 06/30/2026 1174941451
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $70,822.25 05/06/2025 Non-covered Recipient Entity
Florida Cancer Specialists - South
Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer (CA245-0001) No dispute reported 06/30/2026 1235997333
Principal investigator 1 Eli Lilly and Company $16,991.50 03/31/2025 Non-covered Recipient Entity
FLORIDA CANCER SPECIALISTS
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187880081
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $434.58 02/25/2025 Non-covered Recipient Entity
Florida Cancer Specialists - South
Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + nivolumab FDC) in combination with Carboplatin plus Etoposide vs Atezolizumab in combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer (CA245-0001) No dispute reported 06/30/2026 1235997335
Principal investigator 1 Eli Lilly and Company $120.60 02/25/2025 Non-covered Recipient Entity
FLORIDA CANCER SPECIALISTS
A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER No dispute reported 06/30/2026 1187881536